WWM
MYGN icon

Wolff Wiese Magana’s Myriad Genetics MYGN Stock Holding History

Wolff Wiese Magana’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-229
Closed -$2.03K – 1027
2025
Q1 		$2.03K Sell
229
-416
-64% -$5K ﹤0.01% 726
2024
Q4 		$8.84K Hold
645
– – 0.01% 444
2024
Q3 		$17.7K Buy
+645
New +$17.5K 0.01% 336

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Wolff Wiese Magana's MYGN Position: Q2 2025 in Review

Wolff Wiese Magana sold out of Myriad Genetics (MYGN) in Q2 2025, closing a stake of 229 shares — an estimated $2.03K sold.

Wolff Wiese Magana first reported a position in MYGN in Q3 2024 and held it in 3 quarters. The position peaked at $17.7K in Q3 2024. 221 funds tracked by Wall St. Rank hold MYGN as of Q2 2025.

  • Wolff Wiese Magana reported no remaining Myriad Genetics position as of Q2 2025 after selling out during the quarter.
  • Wolff Wiese Magana sold 229 Myriad Genetics shares in Q2 2025, an estimated $2.03K.
  • Wolff Wiese Magana first reported a position in Myriad Genetics in Q3 2024 and held it in 3 quarters.
  • Wolff Wiese Magana's Myriad Genetics position peaked at $17.7K in Q3 2024.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2025.

Based on Wolff Wiese Magana's 13F filing for Q2 2025, filed 17 Jul 2025.